A research team introduces a fully automated, non-destructive phenotyping platform that combines X-ray fluorescence ...
Johnson & Johnson is rated a buy, with accelerating revenue and earnings growth driven by TREMFYA, CARVYKTI, and robust MedTech innovation. JNJ's portfolio reshaping (divesting Orthopaedics and ...
The internet erupted into a frenzy on Monday night after a video of a canned "60 Minutes" segment from Sunday was published. On Sunday, CBS News Editor in Chief Bari Weiss scrapped a segment on "60 ...